CONMED Corporation (CNMD)
Pre-market:
| Previous close | 67.22 |
| Open | 66.57 |
| Bid | 52.48 x 900 |
| Ask | 70.44 x 900 |
| Day's range | 66.57 - 68.81 |
| 52-week range | 61.05 - 138.47 |
| Volume | |
| Avg. volume | 572,324 |
| Market cap | 2.094B |
| Beta (5Y monthly) | 1.34 |
| PE ratio (TTM) | 26.05 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.80 (1.18%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Business Wire
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
LARGO, Fla., April 24, 2024--CONMED Corporation (NYSE: CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company’s commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence.
- Business Wire
CONMED Corporation Announces First Quarter 2024 Financial Results
LARGO, Fla., April 24, 2024--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2024.
- Business Wire
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
LARGO, Fla., April 02, 2024--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
